Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Horm Metab Res. 2016 Aug 2;49(1):50–57. doi: 10.1055/s-0042-111517

Figure 4.

Figure 4.

In vivo FENO treatment does not affect skeletal muscle mitochondrial enzyme activity or genes or proteins linked with PPARα. Skeletal muscle citrate synthase activity (A) mitochondrial ETS complex enzyme activities (B), mRNA content of genes linked with PPARα activation (C) were not different after 10 weeks of FENO treatment, though complete FAO from (14C-labeled palmitate) was increased in fresh skeletal muscle tissue homogenates of a subset of pre-diabetic patients treated with FENO for 10-weeks (A). Data are mean ± SEM. * indicates significant difference from Pre-FENO condition.